The landscape of cervical disease has been revolutionized by the HPV vaccine. By targeting the most oncogenic strains before exposure occurs, the vaccine has the potential to eliminate cervical cancer as a public health problem. Coupled with refined screening algorithms that reduce unnecessary procedures for low-risk patients, the focus of modern gynecology remains firmly on early detection and primary prevention.
These often represent transient HPV infections and are typically managed with observation, as a high percentage regress spontaneously. Topic 52: Cervical Disease and Neoplasia
In conclusion, while cervical neoplasia remains a significant global health burden, particularly in low-resource settings, the clear understanding of its viral etiology provides a robust framework for its eradication. Continued emphasis on vaccination coverage and accessible screening is essential to further reducing the morbidity and mortality associated with this disease. The landscape of cervical disease has been revolutionized
The success of cervical cancer prevention is largely attributed to the implementation of the Papanicolaou (Pap) smear and, more recently, primary HPV testing. These often represent transient HPV infections and are
These are considered "true" precursors to cancer and require treatment to prevent progression. Common excisional procedures include the Loop Electrosurgical Excision Procedure (LEEP) or Cold Knife Conization (CKC).
When screening results are abnormal, colposcopy allows for direct visualization of the cervix under magnification. Aceto-white changes and abnormal vascular patterns (punctation or mosaicism) guide the clinician to perform targeted biopsies, which provide the definitive histological diagnosis of CIN 1, 2, or 3. Management of Neoplasia